Are Fusion on a pathway to finding the Holy Grail ?

Fusion rapidly advancing their R&D MAL validation programme with successful SARS-CoV-2 antigens created for commercial use, moving onto the next step, finding a neutralising antibody for the disease. I meant to cover the news from Fusion Antibodies (FAB) last week when it was announced but the news landed whilst I was under the knife havingContinue reading “Are Fusion on a pathway to finding the Holy Grail ?”

Some FAB some not so…

In the spirit of not just publishing fluff when things go right, I thought I’d pen a few notes on Fusion Antibodies (FAB) as they provided a trading update this week and I am a shareholder! I’ve actually completed a couple of research notes on the company recently, the latest part here As I writeContinue reading “Some FAB some not so…”